A new long-acting antibody (N6LS) combined with CAB LA could make HIV treatment even simpler—potentially requiring just a few injections per year. Researchers are now exploring even longer dosing intervals. #CROI2025 🔗 More details: life4me.plus/en/news/croi...
N6LS Antibody Brings Us Closer to Long-Acting HIV Treatment
This research marks an exciting step toward making HIV treatment easier and less of a daily burden for millions of people worldwide.
life4me.plus